9th International Symposium on the Clinical Use of Cellular Products
First Program
Cellular Therapy 2017 March 16 and 17, 2017, Erlangen, Germany
Universitatsklinikum Erlangen
Universitatsklinikum Erlangen
First Program
9th International Symposium on the Clinical Use of Cellular Products Cellular Therapy 2017
March 16 and 17, 2017
Department of Internal Medicine 5 – Hematology/Oncology University of Erlangen-Nuremberg
Department of Dermatology University of Erlangen-Nuremberg
Department of Internal Medicine 3 – Hematology/Oncology Unversity of Regensburg
Department of Internal Medicine 2 – Hematology/Oncology University of Würzburg Dear Colleagues.
On behalf of the organizing committee we would like to invite you to join us for the 9th International Cellular Therapy Symposium, to be held in Erlangen, Germany, from March 16 to 17, 2017. The Cellular Therapy Symposium will be co-organized by the Universities of Erlangen-Nuremberg (A. Mackensen; G. Schuler), Regensburg (W. Herr), and Würzburg (H. Einsele).
Recent advances in protein engineering and molecular biology have increased the feasibility of cellular therapies such as genetically engineered T cells (CARs & TCRs) to treat malignant diseases.
Over the past years the meeting has evolved to a widely respected event, attracting experts from all over the world to discuss recent topics of the field in a pleasant environment. The upcoming meeting 2017 will focus on immune effector/suppressor cells, CAR/TCR-engineered T-cell therapy, immunological checkpoints, antigen presenting cells / B cells, and immunometabolism.
We are sure that your participation will contribute making the meeting exciting and successful. You are cordially invited to join us at this symposium in the beautiful city of Erlangen.
Yours sincerely
Prof. Andreas Mackensen Universitatsklinikum Erlangen
Organizer: Andreas Mackensen, Erlangen Gerold Schuler, Erlangen Wolfgang Herr, Regensburg Herrmann Einsele, Würzburg
Scientific Committee: Hinrich Abken, Köln Philipp Beckhove, Regensburg Diana Dudziak, Erlangen Matthias Edinger, Regensburg Hermann Einsele, Würzburg Armin Gerbitz, Berlin Wolfgang Herr, Regensburg Michael Hudecek, Würzburg Petra Hoffmann, Regensburg Anita Kremer, Erlangen Marina Kreutz, Regensburg Andreas Mackensen, Erlangen Dimitrios Mougiakakos, Erlangen Evelyn Ullrich, Frankfurt Wolfgang Uckert, Berlin Claudia Rössig, Münster Simone Thomas, Regensburg Gerold Schuler, Erlangen Thomas Winkler, Erlangen Robert Zeiser, Freiburg
Congress Secretary: PD Dr. Dimitrios Mougiakakos Department of Internal Medicine 5 – Hematology and Oncology Ulmenweg 18 D-91054 Erlangen, Germany Phone: +49-9131-85 35954 Fax: +49-9131-85 35958 E-mail: [email protected]
Location: Hörsäle Medizin Universitätsklinikum Erlangen Ulmenweg 18 D-91054 Erlangen, Germany Thursday March 16, 2017
Session I
Immune Effector/Suppressor Cells
09.00 h – 11.15 h
■ Targeting cancer-specific mutations for T-cell therapy Hans Schreiber (Chicago)
■ Myeloid-derived suppressor cells Vincenzo Bronte (Verona)
■ γδ T cells for cancer immunotherapy Jürgen Kuball (Utrecht)
2 – 3 short presentations (selected from submitted abstracts) Universitatsklinikum Erlangen
Thursday March 16, 2017
Session II
TCR-engineered T-Cell Therapy
13.30 h – 15.30 h
■ TCR engineered T-cell immunotherapy Nicholas Restifo (Bethesda)
■ Optimizing T-cell receptor gene therapy for hematologic malignancies Hans M. Stauss (London)
■ T-cell therapy in pancreatic cancer Rink Offringa (Heidelberg)
2 – 3 short presentations (selected from submitted abstracts) Thursday March 16, 2017
Session III
CAR T-Cell Therapy
16.00 h – 18.15 h
■ CAR T cells in leukemia and myeloma Carl H. June (Philadelphia)
■ Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape Nabil M. Ahmed (Houston)
■ Engineering regulatory T cells with chimeric antigen receptors Megan K. Levings (Vancouver)
2 – 3 short presentations (selected from submitted abstracts) Universitatsklinikum Erlangen
Friday March 17, 2017
Session IV
Immunological Checkpoints
09.00 h – 11.15 h
■ PD-L1 and PD-1 pathway blockade for cancer therapy: biomarkers and potential combinations Lieping Chen (Yale)
■ Immunological checkpoints George Coukos (Lausanne)
■ Targeting novel immune checkpoints Philipp Beckhove (Regensburg)
2 – 3 short presentations (selected from submitted abstracts) Friday March 17, 2017
Session V
Antigen Presenting Cells/B-Cells
12.00 h – 14.00 h
■ Molecular mechanisms of antigen processing Peter Cresswell (Yale)
■ Dendritic cell and macrophage ontogeny Florent Ginhoux (Singapore)
■ Trastuzumab emtansine renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade Alfred Zippelius (Basel)
2 – 3 short presentations (selected from submitted abstracts) Universitatsklinikum Erlangen
Friday March 17, 2017
Session VI
Immunometabolism
14.15 h – 16.15 h
■ Overcoming metabolic checkpoints to anti-tumor immunity Greg M. Delgoffe (Pittsburgh)
■ Immunometabolic regulation of lymphocyte function Christoph Hess (Basel)
■ Metabolic checkpoints of anti-tumor T cell responses Ping-Chih Ho (Lausanne) General Information
Scientific Sessions:
■ Immune Effector/Suppressor Cells ■ CAR/TCR-engineered T-Cell Therapy ■ Immunological Checkpoints ■ Antigen Presenting Cells / B-Lymphocytes ■ Immunometabolism
Submission of Abstracts: Deadline: January 20, 2017
Abstract submission will be available on the Cellular Therapy website beginning November 1, 2016. To submit an abstract for consideration and review, please go to
http://www.cellular-therapy.de
and click on Abstract Submission icon. Submission instructions and guidelines will appear.
All abstracts selected for oral or poster presentation will be printed in an abstract book, available to the participants. Universitatsklinikum Erlangen
Registration:
Participants are given the opportunity to register for the symposium online. Please adhere to the instructions given on the symposium website
http://www.cellular-therapy.de
Registration fee:
Pre-registration On site- (before Feb. 15, 2017) registration
Full Registration: 275 € 350 €
Students: 150 € 225 €
Members of Uni R or ER or WÜ: 75 € 100 €
The registration fee covers conference volume, coffee breaks, lunch and social event
Please register early as attendance will be limited to 350 participants!!! Hotel Reservation:
For further information please contact:
Erlanger Tourismus und Marketing Verein e.V. Carree am Rathausplatz Rathausplatz 3 91052 Erlangen Phone: ++49 (0)9131 8951-11 Fax: ++49 (0)9131 8951-51 E-mail: [email protected] E-mail: [email protected]
Poster Presentation:
Posters (100 cm wide and 120 cm high) Deadline for abstracts: January 20, 2017 Universitatsklinikum Erlangen Congress Secretary: PD Dr. Dimitrios Mougiakakos Department of Internal Medicine 5 – Hematology and Oncology Ulmenweg 18 D-91054 Erlangen, Germany Phone: +49-9131-85 35954 Fax: +49-9131-85 35958 E-mail: [email protected]